Clinical Trials Browser

Phase 1/2 × Brain Neoplasms × Imatinib Mesylate × Clear all

Brain Neoplasms, Glioma, Oligodendroglioma

NCT00010049 2018-06-27

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Clinical Trials

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma